13F Data
13F filer · CIK 1671207

Atlas Venture Associates IX, LLC

Boston, MA · filing since Q4 2016 · last filing Nov 13, 2023
Reported value
$11.8M
$-6.5M vs prior
Positions
6
New / sold out
2 / 2
Added / reduced
0 / 0
Turnover
17.5%
buys $2.6M · sells $3.7M
Top-10 weight
100.0%

Biggest buys vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
NewCOHERUS BIOSCIENCES INC+568,408–+$2.1M
NewSYNLOGIC INC+176,798–+$496.8K

Biggest sells vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
Sold outSURFACE ONCOLOGY INC-2,945,453-100.0%$-2.6M
Sold outSYNLOGIC INC-2,651,963-100.0%$-1.1M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2016: $58.1MQ1 2017: $52.6MQ2 2017: $62.3MQ3 2017: $141.6MQ4 2017: $112.9MQ1 2018: $132.3MQ2 2018: $227.2MQ3 2018: $188.9MQ4 2018: $86.9MQ1 2019: $106.5MQ2 2019: $93.5MQ3 2019: $60.8MQ4 2019: $57.4MQ1 2020: $47.3MQ2 2020: $93.5MQ3 2020: $96.7MQ4 2020: $631.0MQ1 2021: $595.2MQ2 2021: $568.4MQ3 2021: $300.9MQ4 2021: $229.1MQ1 2022: $108.7MQ2 2022: $44.0MQ3 2022: $33.7MQ4 2022: $20.1MQ1 2023: $21.3MQ2 2023: $18.3MQ3 2023: $11.8M
Q4 2016Q3 2023

Holdings · Q3 2023

#SecuritySharesValueWeight
1SKILLZ INCCOM1,145,492$5.8M49.69%
2COHERUS BIOSCIENCES INCCOM568,408$2.1M18.08%
3SPERO THERAPEUTICS INCCOM1,353,303$1.6M13.93%
4SNAP INCCL A150,160$1.3M11.38%
5SYNLOGIC INCCOM176,798$496.8K4.23%
6INTELLIA THERAPEUTICS INCCOM10,000$316.2K2.69%